Fin Trust Capital Advisors, LLC Spring Works Therapeutics, Inc. Call Options Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SWTX
# of Institutions
239Shares Held
70.8MCall Options Held
151KPut Options Held
255K-
Vanguard Group Inc Valley Forge, PA7.16MShares$411 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$323 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$199 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$188 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$172 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.58B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...